These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9196168)

  • 1. A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests.
    Langedijk JP; Brandenburg AH; Middel WG; Osterhaus A; Meloen RH; van Oirschot JT
    J Clin Microbiol; 1997 Jul; 35(7):1656-60. PubMed ID: 9196168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G.
    Langedijk JP; Middel WG; Schaaper WM; Meloen RH; Kramps JA; Brandenburg AH; van Oirschot JT
    J Immunol Methods; 1996 Jun; 193(2):157-66. PubMed ID: 8699029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
    Martínez I; Dopazo J; Melero JA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of antibodies to respiratory syncytial virus attachment and nucleocapsid proteins with recombinant baculovirus-expressed antigens.
    Buraphacheep W; Britt WJ; Sullender WM
    J Clin Microbiol; 1997 Feb; 35(2):354-7. PubMed ID: 9003595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.
    Erdman DD; Anderson LJ
    J Clin Microbiol; 1990 Dec; 28(12):2744-9. PubMed ID: 2280004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response.
    Akerlind-Stopner B; Utter G; Norrby E; Mufson MA
    J Med Virol; 1995 Oct; 47(2):120-5. PubMed ID: 8830114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
    Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
    J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly.
    Sastre P; Cusi MG; Manoha C; Schildgen O; Ruiz T; Vela C; Rueda P
    J Virol Methods; 2010 Sep; 168(1-2):170-6. PubMed ID: 20488207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus.
    Cane PA
    J Med Virol; 1997 Apr; 51(4):297-304. PubMed ID: 9093944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.
    Brandenburg AH; Groen J; van Steensel-Moll HA; Claas EC; Rothbarth PH; Neijens HJ; Osterhaus AD
    J Med Virol; 1997 May; 52(1):97-104. PubMed ID: 9131465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.
    Melero JA; García-Barreno B; Martínez I; Pringle CR; Cane PA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2411-8. PubMed ID: 9349459
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
    Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
    J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.
    López JA; Andreu D; Carreño C; Whyte P; Taylor G; Melero JA
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2567-77. PubMed ID: 7506298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
    Palomo C; Cane PA; Melero JA
    J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus.
    Nicholas JA; Mitchell MA; Levely ME; Rubino KL; Kinner JH; Harn NK; Smith CW
    J Virol; 1988 Dec; 62(12):4465-73. PubMed ID: 2460636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo.
    Chargelegue D; Obeid OE; Hsu SC; Shaw MD; Denbury AN; Taylor G; Steward MW
    J Virol; 1998 Mar; 72(3):2040-6. PubMed ID: 9499058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses against the G and F proteins of bovine respiratory syncytial virus after experimental and natural infections.
    Schrijver RS; Langedijk JP; van der Poel WH; Middel WG; Kramps JA; van Oirschot JT
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):500-6. PubMed ID: 8877125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.
    Zhang Y; Brooks WA; Goswami D; Rahman M; Luby SP; Erdman DD
    J Virol Methods; 2014 Sep; 206():55-62. PubMed ID: 24859050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses of children to the C-terminal peptide of the SH protein of respiratory syncytial virus and the immunological characterization of this protein.
    Akerlind-Stopner B; Hu A; Mufson MA; Utter G; Norrby E
    J Med Virol; 1993 Jun; 40(2):112-20. PubMed ID: 8360632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Respiratory syncytial virus and immune response: from the diagnosis of infection to prospects of vaccination].
    Pothier P
    Pediatrie; 1991; 46(8-9 Suppl):1-4. PubMed ID: 1665219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.